Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.
The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
17 December 2024 - preview of changes for January 2025
Pharmaceutical |
Change |
Amikacin (Biomed) inj 5 mg per ml, 5 ml |
price increase |
Amiloride hydrochloride (Biomed) oral liq 1 mg per ml, 25 ml |
price increase |
Atracurium besylate inj 10 mg per ml, 2.5 ml and 5 ml ampoule |
Brand change Medsurge – new listing and addition of PSS
Tracrium to be delisted 1 June 2025 |
Atropine sulphate (Hikma) inj 600 mcg per ml, 1 ml ampoule |
new listing (p’code 2693976) |
Budesonide with glycopyrronium and eformoterol (Breztri Aerosphere) aerosol inhaler budesonide 160 mcg with glycopyrronium 7.2 mcg and formoterol 5 mcg per dose, 120 dose |
new listing (p’code 2656841) |
Bupivacaine hydrochloride with fentanyl (Biomed) inj 0.625 mg with fentanyl 2 mcg per ml, 200 ml bag and inj 1.25 mg with fentanyl 2 mcg per ml, 20 ml syringe |
price increase |
Caffeine citrate (Biomed) oral liq 20 mg per ml (caffeine 10 mg per ml), 25 ml and inj 20 mg per ml (caffeine 10 mg per ml), 2.5 ml ampoule |
price increase |
Calcitriol (Calcitriol-AFT) cap 0.25 mcg |
new listing (p’code 2695154) |
Cetirizine hydrochloride (Histaclear) oral liq 1 mg per ml, 200 ml |
price increase |
Cetomacrogol (Cetomacrogol Cream AFT) crm BP, 100 g |
new listing and addition of PSS (p’code 2696673) |
Clomipramine hydrochloride (Clomipramine Teva) cap 10 mg and 25 mg |
price increase |
Chlorothiazide (Biomed) oral liq 50 mg per ml, 25 ml |
price increase |
Cocaine hydrochloride (Biomed) soln 4%, 2 ml syringe |
price increase |
Covid-19 vaccine (Comirnaty Omicron (JN.1)) inj 3 mcg bretovameran per 0.3 ml, 0.48 ml vial; infant vaccine, yellow cap; inj 10 mcg bretovameran per 0.3 ml, 0.48 ml vial; paediatric vaccine, light blue cap and inj 30 mcg bretovameran per 0.3 ml, 0.48 ml vial; adult vaccine, light grey cap |
new listing
|
Covid-19 vaccine (Comirnaty Omicron (XBB.1.5))
|
to be delisted 1 February 2025 |
Cyclopentolate hydrochloride (Cyclogyl) eye drops 1%, 15 ml |
price increase |
Cytarabine (Pfizer) inj 20 mg per ml, 5 ml vial |
new Pharmacode listing (p’code 2695758) |
Dantrolene (Dantrium) cap 25 mg |
new Pharmacode listing (p’code 2648946) Pharmacode 252409 to be delisted 1 April 2025 |
Dexamethasone (Biomed) oral liq 1 mg per ml, 25 ml |
price increase |
Durvalumab (Imfinzi) inj 50 mg per ml, 2.4 ml and 10 ml vial |
amended restriction criteria
|
Econazole nitrate (Pevaryl) crm 1%, 20 g |
new listing, addition of PSS and |
Eftrenonacog alfa [recombinant factor IX] (Alprolix) inj 250 iu, 500 iu, 1,000 iu, 2,000 iu, 3,000 iu and 4,000 iu vial |
new Pharmacode listing
|
Erlotinib (Alchemy) tab 100 mg and 150 mg |
amended restriction criteria |
Erythromycin (as ethylsuccinate) (E-Mycin) tab 400 mg and grans for oral liq 200 mg and 400 mg per 5 ml, 100 ml |
price increase |
Flecainide acetate (Tambocor German) inj 10 mg per ml, 15 ml ampoule |
new listing (p’code 2696967) |
Fluconazole (Fluconazole-Baxter) inj 2 mg per ml, 50 ml and 100 ml vial |
price increase |
Folic acid (Biomed) oral liq 50 mcg per ml, 25 ml |
price increase |
Gefitinib (Iressa) tab 250 mg |
amended restriction criteria |
High protein oral feed 2.4 kcal/ml (e.g. Fortisip Compact Protein) liquid 14.6 g protein, 25.3 g carbohydrate and 9.6 g fat per 100 ml, 125 ml bottle |
removal of note and delisted date revoked |
Hydrocortisone acetate (Colifoam) rectal foam 10%, CFC free (14 applications), 15 g |
price increase |
Iohexol (Omnipaque) inj 350 mg per ml (iodine equivalent), 75 ml bottle |
to be delisted 1 June 2025 |
Iron polymaltose (Ferrosig) inj 50 mg per ml, 2 ml ampoule |
price increase |
Ketamine (Biomed) inj 1 mg per ml, 100 ml bag and inj 10 mg per ml, 10 ml syringe |
price increase |
Lidocaine [lignocaine] hydrochloride (Lidocaine-Baxter) inj 1%, 5 ml ampoule and 20 ml vial and inj 2%, 5 ml ampoule and 20 ml vial |
price increase |
Lidocaine [lignocaine] hydrochloride with adrenaline and tetracaine hydrochloride (Topicaine) soln 4% with adrenaline 0.1% and tetracaine hydrochloride 0.5%, 5 ml syringe |
price increase |
Methylphenidate hydrochloride tab immediate-release 10 mg (Ritalin) and cap modified-release 10 mg, 20 mg, 30 mg and 40 mg |
price increase |
Osimertinib (Tagrisso) tab 40 mg and 80 mg |
new listing · Tab 40 mg (p’code 2536358) · Tab 80 mg (p’code 2536331) |
Palivizumab (Synagis) inj 100 mg per ml, 1 ml vial |
new listing (p’code 2621835) |
Potassium citrate (Biomed) oral liq 3 mmol per ml, 200 ml |
price increase |
Promethazine hydrochloride (Phenergan Elixir) oral liq 1 mg per ml, 100 ml |
new listing (p’code 692700) |
Risperidone (Risperdal) tab 4 mg |
new listing (p’code 245402) |
Spironolactone (Biomed) oral liq 5 mg per ml, 25 ml |
price increase |
Sodium bicarbonate (Biomed) inj 8.4%, 50 ml and 100 ml vial |
price increase |
Sodium chloride (Biomed) nebuliser soln 7%, 90 ml bottle, 90 ml and inj 23.4% (4 mmol/ml), 20 ml ampoule |
price increase |
Sodium dihydrogen phosphate [sodium acid phosphate] (Biomed) inj 1 mmol per ml, 20 ml ampoule |
price increase |
Sodium fusidate [fusidic acid] (Fucithalmic) eye drops 1%, 5 g |
new listing (p’code 2697572) |
Solifenacin succinate tab 5 mg and 10 mg |
Brand change Solifenacin succinate Max Health – new listing and addition of PSS
Solifenacin Viatris to be delisted 1 June 2025 |
Sucrose (Biomed) oral liq 25%, 25 ml |
price increase |
Trastuzumab deruxtecan (Enhertu) inj 100 mg per ml, 1 ml vial |
new listing (p’code 2678276) |
Trastuzumab emtansine (Kadcyla) inj 100 mg and 160 mg vial |
amended restriction criteria
|
Tropicamide (Mydriacyl) eye drops 0.5% and 1%, 15 ml |
price increase |